RIDA®PRECISION pharmacogenetic tests

Pharmacogenomics combines pharmacology and genomics to develop effective and safe drugs that will be tailored to a persons genetic constitution. Currently many drugs that are available are “one size fits all”, it is difficult to predict who will benefit from a medication, who will experience side effects and who will not respond at all.

Our depression gene test RIDA®PRECISION ABCB1 analyses specific gene variants to predict which medication will be effective for a particular person and help to prevent adverse drug reactions.

Depression gene test ABCB1

Depression is one of the most serious mental disorders being estimated to affect about 350 million people worldwide. The RIDA®PRECISION ABCB1 test predicts which antidepressants are best suited for the individual patient.

Start typing and press Enter to search